A short film that premiered earlier this month tracks the journeys of three people who discovered a renewed commitment to ...
Novartis is pricing Itvisma at a wholesale acquisition cost of $2.59 million, a company spokesperson told Fierce Pharma. At ...
A recent survey has found that pharma marketing and promotional review professionals are skeptical of the outputs of ...
Less than a week after Novartis unveiled a plan to establish a “flagship manufacturing hub” in North Carolina that would add ...
The U.K. drug marketing watchdog has ruled that a presentation calling the European Medicines Agency (EMA) “stupid” brought ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback